Curis to Present at the Wall Street Analyst Forum's 18th Annual Analyst Conference.- Conference is focused on Biotech & Specialty Pharma - CAMBRIDGE, Mass. -- Curis, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CRIS), a drug development company focused on seeking to develop proprietary targeted medicines primarily for cancer treatment, today announced that the Company will be presenting at the Wall Street Analyst Forum's 18th Annual Conference on September 20, 2007, at the Princeton Club The Princeton Club of New York is a social organization in New York City catering to faculty and alumni of Princeton University in Princeton, New Jersey. Incorporated on Dec. 7, 1899, the club has had four homes before settling into its current clubhouse at 15 W. in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . Daniel Passeri, Curis' President and Chief Executive Officer, will conduct a 40-minute presentation, including a question and answer session, at 1:20 p.m. Eastern Time on September 20, 2007. Mr. Passeri's presentation will provide an overview of the status of Curis' business, including its small molecule cancer research and development programs. There will also be a corresponding webcast of the presentation, which can be accessed by visiting: http://www.wsw.com/webcast/rrshq11/cris The presentation will be archived shortly after the live event and available for 30 days following the conference. In addition, it will also be available for 30 days on the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of the Curis website at www.curis.com. About Curis, Inc. Curis, Inc. is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new medicines, primarily for cancer. In expanding its drug development efforts in the field of cancer through its Targeted Cancer Drug Development Platform, Curis is building upon its previous experiences in targeting signaling pathways in the areas of cancer, neurological disease Noun 1. neurological disease - a disorder of the nervous system nervous disorder, neurological disorder disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; and cardiovascular disease Cardiovascular disease Disease that affects the heart and blood vessels. Mentioned in: Lipoproteins Test cardiovascular disease . For more information, visit Curis' website at www.curis.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion